SCHEMBL3847142

SCHEMBL3847142

CO[C@H]1CN(c2ccnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)C5C=CC=CC5)nc4-c4ccc(F)cc4)cc23)C[C@@H]1OC

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 2/20 0.31
CSNK1E P49674 2/20 0.31
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847998 0.90 CHRM4 (0.38)
SCHEMBL3846326 0.89
SCHEMBL3847140 0.86 CSNK1D (0.35) CSNK1DCSNK1EKCNH2
SCHEMBL3847629 0.84 CSNK1D (0.33) CSNK1DCSNK1EKCNH2
SCHEMBL3846403 0.83 LRRK2 (0.31)
SCHEMBL3857330 0.82 THRB (0.31) CSNK1DCSNK1EKCNH2
SCHEMBL3847729 0.82 PIK3CD (0.34)
SCHEMBL3855590 0.81 LMNA (0.35)
SCHEMBL3847547 0.81 SLC22A12 (0.30)
SCHEMBL3850510 0.80 CYP3A4 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed